Roderick Paul J, Atkins Richard J, Smeeth Liam, Mylne Adrian, Nitsch Dorothea D M, Hubbard Richard B, Bulpitt Christopher J, Fletcher Astrid E
Public Health Sciences and Medical Statistics, University of Southampton, Southampton General Hospital, Southampton, UK.
Am J Kidney Dis. 2009 Jun;53(6):950-60. doi: 10.1053/j.ajkd.2008.12.036. Epub 2009 Apr 25.
The prevalence of chronic kidney disease (CKD) increases with age; however, the prognostic significance in older people is uncertain. This study aims to determine the association of CKD with all-cause and cardiovascular mortality in community-dwelling older people 75 years and older.
Cohort study of people 75 years and older recruited in 1994 to 1999 to 1 arm of a trial of multidimensional health assessment with mortality follow-up.
SETTING & PARTICIPANTS: 53 general practices in Great Britain. 15,336 (73%) of those eligible participated. 13,177 (86%) had serum creatinine measured at baseline.
Estimated glomerular filtration rate (eGFR).
All-cause and cardiovascular mortality.
eGFR derived from serum creatinine level using the 4-variable Modification of Diet in Renal Disease (MDRD) Study equation in milliliters per minute per 1.73 m(2); dipstick proteinuria. Mortality by linkage to national death registration and death certification.
After a median follow-up of 7.3 years (interquartile range, 5.0), 7,633 (58%) had died, 42% of cardiovascular causes. In the first 2 years of follow-up, adjusted hazard ratios for all-cause mortality in eGFR bands of 45 to 59, 30 to 44, and less than 30 compared with eGFR greater than 60 mL/min/1.73 m(2) were 1.13 (95% confidence interval, 0.93 to 1.37), 1.69 (95% confidence interval, 1.26 to 2.28), and 3.87 (95% confidence interval, 2.78 to 5.38) in men and 1.14 (95% confidence interval, 0.93 to 1.40), 1.33 (95% confidence interval, 1.06 to 1.68), and 2.44 (95% confidence interval, 1.68 to 3.56) in women, respectively. Hazard ratios were greater for cardiovascular mortality and lower after 2 years. Dipstick proteinuria was independently associated with all-cause, but not cardiovascular, mortality risk in both sexes.
Single serum creatinine measurement, no calibration of serum creatinine, MDRD Study equation not validated in older people.
As kidney function decreases, there is a graded and independent increase in all-cause and cardiovascular mortality risk in older people 75 years and older, especially in men and those with eGFR less than 45 mL/min/1.73 m(2). Dipstick proteinuria did not add to cardiovascular mortality risk in this elderly population. In older people, identification and management of CKD should prioritize the smaller numbers with more severe CKD.
慢性肾脏病(CKD)的患病率随年龄增长而升高;然而,其在老年人中的预后意义尚不确定。本研究旨在确定社区居住的75岁及以上老年人中CKD与全因死亡率和心血管死亡率之间的关联。
对1994年至1999年招募的75岁及以上人群进行队列研究,该研究是一项多维健康评估试验的一部分,并对死亡率进行随访。
英国的53家全科诊所。符合条件的参与者中有15336人(73%)参与。13177人(86%)在基线时测量了血清肌酐。
估计肾小球滤过率(eGFR)。
全因死亡率和心血管死亡率。
使用4变量的肾脏疾病饮食改良(MDRD)研究方程,根据血清肌酐水平得出eGFR,单位为每分钟每1.73平方米毫升数;试纸法检测蛋白尿。通过与国家死亡登记和死亡证明进行关联来确定死亡率。
中位随访7.3年(四分位间距为5.0年)后,7633人(58%)死亡,42%死于心血管疾病。在随访的前2年,与eGFR大于60 mL/min/1.73平方米相比,eGFR处于45至59、30至44以及低于30区间的男性全因死亡率调整后风险比分别为1.13(95%置信区间为0.93至1.37)、1.69(95%置信区间为1.26至2.28)和3.87(95%置信区间为2.78至5.38),女性分别为1.14(95%置信区间为0.93至1.40)、1.33(95%置信区间为1.06至1.68)和2.44(95%置信区间为1.68至3.56)。心血管死亡率的风险比更高,且2年后降低。试纸法检测蛋白尿与两性的全因死亡率独立相关,但与心血管死亡率无关。
单次测量血清肌酐,未对血清肌酐进行校准,MDRD研究方程未在老年人中验证。
随着肾功能下降,75岁及以上老年人的全因死亡率和心血管死亡率风险呈分级且独立增加,尤其是男性以及eGFR低于45 mL/min/1.73平方米的人群。在该老年人群中,试纸法检测蛋白尿并未增加心血管死亡率风险。对于老年人,CKD的识别和管理应优先关注病情更严重的少数患者。